BSEInsider Trading / SAST17h ago · 25 Sept 2026, 06:12 pm
Closure of trading window for the quarter ended September 30, 2026
Onesource Specialty Pharma Ltd · 544292
✦ AI SummaryResults
Onesource Specialty Pharma Ltd has announced the closure of its trading window for the quarter ended September 30, 2026, until 48 hours after the declaration of financial results.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Onesource Specialty Pharma Ltd - 544292 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
03966f67-d528-496d-a755-8870e37234f0.pdf
View document text
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi,
560076, India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
Date: September 24, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra Kurla Complex,
Dalal Street, Mumbai- 400001 Bandra (E), Mumbai – 400 051
Scrip Code: 544292 Symbol: ONESOURCE
Dear Madam/ Sirs,
Subject: Intimation regarding closure of Trading Window
Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations,
2015 and Code of Conduct for Prohibition of Insider Trading of OneSource Specialty Pharma Limited (“Company”),
for regulating, monitoring and reporting of trading by insiders, we hereby inform you that the Trading Window for
dealing in shares of the Company shall remain closed from Thursday, October 01, 2026, until 48 hours after declaration
of the financial results of the Company for the quarter ended September 30, 2026.
The date of the Board Meeting for declaration of financial results of the Company for the quarter ended September 30,
2026, will be intimated in due course.
Kindly take the above information on record.
For and on behalf of
OneSource Specialty Pharma Limited
Trisha A
Company Secretary and Compliance Officer
Membership Number: A47635
OneSource Specialty Pharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497